Walter E. Washington Convention Center
Washington, D.C.
May 16-19, 2022

  • Source: Andelyn Biosciences By Kristin Heller, Plasmid Core Manager, and Andy Moreo, Head of Process Development, Plasmid and Viral Vector Core Facilities, Andelyn Biosciences GettyImages-517743436-plasmid-dna-development-lab The proliferation of targeted cell and gene therapies as first-line treatments for many rare and complex disease states has spurred... Learn More

  • G-CON, the leader in off-site prefabricated, flexible cleanroom solutions, today announced its capabilities to manufacture and deliver the company's signature standardPOD cleanrooms in Europe.  standardPODs, launched in the U.S. in 2020, are off-the-shelf cleanrooms designed to maximise efficiencies related to production, qualification, delivery and cost reduction and provide timeline certainty... Learn More

  • Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in... Learn More